- medneo UK is a leading mobile diagnostic imaging company, specialising in MRI and CT services
- CVC DIF will partner with medneo UK’s experienced management team to continue to enhance patient outcomes across the UK
CVC DIF, the infrastructure strategy of leading global private markets manager CVC (via its CIF III fund), is pleased to announce the acquisition from medneo Group of medneo UK, a leading diagnostic imaging company, specialising in the provision of mobile MRI and CT scanners, and imaging services.
medneo UK is an expert provider of diagnostic imaging services to NHS Trusts and healthcare providers across the UK. Through its fleet of more than 20 state-of-the-art mobile scanners and its London centre, the business’ highly skilled team of radiographers provide MRI and CT imaging services to more than 130,000 patients a year. medneo UK’s existing management team will continue to lead the company under CEO, Andy Spellman.
medneo UK will be acquired from medneo Group S.A., an innovative diagnostic-imaging operator solution with operations in the UK, Germany and Switzerland. medneo’s UK business was established in 2018.
We are delighted to have agreed to support the next stage of medneo UK’s growth journey. medneo UK has an excellent reputation for providing essential services within the UK healthcare system that improve patient outcomes.
Willem JansoniusPartner and Head of CIF Investments at CVC DIF
Willem Jansonius, Partner and Head of CIF Investments at CVC DIF, says: “We are delighted to have agreed to support the next stage of medneo UK’s growth journey. medneo UK has an excellent reputation for providing essential services within the UK healthcare system that improve patient outcomes. We look forward to working with Andy Spellman and his team to continue to grow the business including providing further investment to expand their fleet of scanners.”
Andy Spellman, CEO of medneo UK, added: “Myself and the whole medneo UK team look forward to working in partnership with CVC DIF to continue to deliver outstanding services for our patients and customers. medneo UK’s success to date is due to the hard work of the medneo UK team, and with CVC DIF’s support we will be able to expand our services to serve even more patients whilst maintaining our focus on exemplary patient and customer care.”
CVC DIF has been advised by Travers Smith (legal advisor), LEK (commercial advisor), KPMG (financial and tax advisor) and Marsh (insurance advisor). medneo Group has been advised by Alantra (corporate finance advisor), Freeths (legal advisor), BDO (financial and tax advisor) and CIL (commercial advisor).
